Risk factor
Poor trading liquidity
Profitability factor
Favourable analyst view
About
Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products comprising vitamins and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system,...
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. In particular, the stock is underpriced on P/E, of fair value on
Target Price
The average target price of 7148.KL is 1.7 and suggests 36% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell